SIBN SI-BONE Inc: חוב להון עצמי

SI-BONE, Inc. (SIBN) dominates the joint fixation niche, covering the global spinal surgery market. The physician training ecosystem solidifies iFuse's status as the industry standard, while the expansion of the sales network mitigates insurance reimbursement risks. The total debt-to-equity ratio on the GURU.Markets chart demonstrates financial stability, where 0.22 serves as the current metric level.

This ratio measures the proportion of borrowed funds relative to equity, determining the company's degree of financial leverage. High values signal increased risks, whereas a decrease in the indicator confirms balance sheet stability. By analyzing the capital structure—the debt-to-equity ratio—an investor assesses the balance between expansion and solvency. For SI-BONE, Inc. (SIBN), moderate leverage enables the scaling of implant deliveries to the hospital sector. Diversification of sales channels minimizes debt risks amid fluctuations in insurance reimbursements.